Stopping antithrombotic therapy may be the most modifiable mechanism behind adverse cardiovascular outcomes after gastrointestinal bleeding.

Expert Rev Gastroenterol Hepatol. 2012;6(2):211-221. Finally, a prospective case series analysis which enrolled 20,621 patients undergoing PCI for all indications from the year 2000 to 2010, across a ...

Please provide your email address to receive an email when new articles are posted on . Patients implanted with a left ventricular assist device as destination therapy and those with a prior history ...

Neena Abraham, MD, of the Scottsdale, Ariz.-based Mayo Clinic, and colleagues conducted a retrospective, propensity-matched study using Optum Labs claims data. Researchers examined rivaroxaban versus ...

Among Medicare-certified, single-specialty ASCs, endoscopy is the most common focus, and more than one-third (37%) 1 of certified multi-specialty ASCs have an endoscopy service line. Patient volumes ...

Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

Some antidepressant medications carry a significant risk of upper-GI hemorrhage. The risk more than triples when the patient also takes certain painkillers. Data from four studies involving 153,000 ...

Gastrointestinal (GI) bleeding is a common and potentially life-threatening condition that requires prompt and accurate diagnosis. Esophagogastroduodenoscopy (EGD) and colonoscopy are the primary ...

Treatment with thalidomide led to a reduction in bleeding among patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), a randomized trial showed. In 150 patients, 68.6% of ...

Pantoprazole yields lower clinically important upper GI bleeding, with no significant change in mortality vs placebo. HealthDay News — Pantoprazole results in a significantly lower risk for clinically ...